逍遥散配合米氮平片治疗精神分裂症后抑郁的临床效果  被引量:6

Clinical Effect of Xiaoyao Powder Combined with Mirtazapine Tablets in the Treatment of Post Schizophrenia Depression

在线阅读下载全文

作  者:陈孔树 陈明 吴祖美 吴琪琪 CHEN Kongshu;CHEN Ming;WU Zumei;WU Qiqi(Ningde Rehabilitation Hospital,Ningde 352100,China;不详)

机构地区:[1]宁德市康复医院,福建宁德352100 [2]福州神经精神病防治院 [3]宁德市中医院

出  处:《中外医学研究》2021年第24期144-146,共3页CHINESE AND FOREIGN MEDICAL RESEARCH

摘  要:目的:对精神分裂症后抑郁采用米氮平联合逍遥散治疗的效果进行观察。方法:选取本科室82例精神分裂症后抑郁患者,时间为2020年1月-2021年1月,随机抽签法分为对照组(41例,米氮平)与观察组(41例,米氮平+逍遥散),对比两组疗效。结果:治疗后观察组HAMD、HAMA评分均低于对照组(P<0.05);观察组总有效率为97.56%,高于对照组的82.93%(P<0.05);治疗后,观察组各康复指标评分均低于对照组(P<0.05);两组不良反应发生率比较差异无统计学意义(P>0.05)。结论:对精神分裂后抑郁患者采用米氮平联合逍遥散治疗,对患者心理状态改善明显,可有效改善患者临床症状,对患者康复效果提升有促进作用,值得推广。Objective:To observe the effect of Mirtazapine combined with Xiaoyao Powder in the treatment of post schizophrenia depression.Method:A total of 82 patients with post schizophrenic depression in our department from January 2020 to January 2021 were divided into control group(41 cases,Mirtazapine)and observation group(41 cases,Mirtazapine+Xiaoyao Powder)by random drawing.The efficacy of the two groups was compared.Result:After treatment,the HAMD and HAMA scores of the observation group were lower than those of the control group(P<0.05).The total effective rate of the observation group was 97.56%,which was higher than 82.93%of the control group(P<0.05);after treatment,the rehabilitation index scores of the observation group were lower than those of the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Mirtazapine combined with Xiaoyao Powder in the treatment of post schizophrenic depression can significantly improve the psychological state of patients,effectively improve the clinical symptoms of patients,and promote the rehabilitation effect of patients,which is worthy of promotion.

关 键 词:精神分裂症 抑郁 米氮平 逍遥散 康复效果 

分 类 号:R749.3[医药卫生—神经病学与精神病学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象